help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJRCCM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leung, C. C.
Right arrow Articles by Yew, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leung, C. C.
Right arrow Articles by Yew, W. W.
American Journal of Respiratory and Critical Care Medicine Vol 177. pp. 939-940, (2008)
© 2008 American Thoracic Society
doi: 10.1164/rccm.200802-340ED


Editorials

Screening Contacts of Tuberculosis

Overcoming Obstacles with an Old Tool

Chi Chiu Leung, M.B.

Tuberculosis and Chest Service
Department of Health
Hong Kong, China

William C. Bailey, M.D.

University of Alabama at Birmingham Lung Health Center
Birmingham, Alabama

Wing Wai Yew, M.B.

Tuberculosis and Chest Unit
Grantham Hospital
Hong Kong, China

In this issue of the Journal (pp. 1041–1047), Aissa and coworkers provide a model for predicting the risk of infection among contacts of patients with tuberculosis (TB) in a suburb of Paris (1). Latent TB infection (LTBI) status among the contacts was established using the traditional tuberculin skin test (TST), despite high bacille Calmette-Guérin (BCG) vaccination coverage. Eight independent risk factors were identified, including index characteristics of cavity and sputum smear (>=100 acid-fast bacilli per field), and contact characteristics of age, active smoking, household exposure at night, first-degree family relationship, birth in higher incidence country, and free health care. The sensitivity, specificity, and the positive predictive values of this model were 0.93, 0.34, and 0.36, respectively, similar to those reported in another population (2).

While IFN-{gamma} release assays (IGRAs) might offer some advantages over traditional TST in terms of specificity, absence of boosting, and requirement of only a single visit (3), these tests measure the host immune responses rather than microbial pathogenicity. Host immune response may be affected by many factors, and the time pattern is not necessarily concordant with the activity of the infecting pathogen. Furthermore, on average, only 10% of infected individuals will ever develop clinical TB disease in their lifetime (4). Using development of disease as the endpoint, the positive predictive values are necessarily low for all existing diagnostic tools for LTBI (46). With these intrinsic limitations, it is not realistic to expect a perfect diagnostic tool for LTBI in the near future.

To maximize the cost-effectiveness in detecting LTBI, the number of persons to be screened should be reduced by targeting those with the highest risk for infection and/or disease. With a predictive model involving only simple index and contact characteristics, Aissa and coworkers were able to reduce the number of contacts to be screened by 26% while maintaining a false-negative rate parallel to the estimated background LTBI prevalence of 8% (1). Such reduction, although modest, highlights the potential utility of further risk stratification even among a conventionally targeted group, in line with the findings of a previous study (7). Better characterization of infection and disease risks will therefore help to inform decisions in the targeted screening of LTBI.

In the absence of a gold standard, much uncertainty remains regarding the actual sensitivity and specificity of the currently available diagnostic tools for LTBI (3, 4). Cross-reaction between Mycobacterium tuberculosis antigens with BCG antigens is a well-known limitation of TST (4). Despite the intrinsic difficulty in verifying vaccination status, BCG vaccination at infancy does not appear to affect the interpretation of TST significantly in adulthood (8, 9). However, revaccination was a common practice in many places until relatively recent reports cast serious doubt regarding its additional efficacy (10). Significant discrepancies were also found between the performance of TST and IGRAs among adults with previous BCG vaccinations (3). The specificity for TST is known to increase with higher cutoff points (4), but the trade-off in sensitivity can be substantial (46). Recommendations vary regarding whether a different cutoff should be used for interpretation of TST among BCG-vaccinated TB contacts. Various cutoff points (5, 10, and 15 mm) have been used in different areas (4, 5, 11). The model of Aissa and coworkers is heavily dependent on the validity of one of its underlying assumptions, that the optimal TST cutoff point is 15 mm for BCG-vaccinated individuals (11).

Theoretically, a higher proportion of recent infection is likely to be found among contacts. Higher TST readings could possibly be found among those recently infected (5), or there could even be generally augmented TST response among previously vaccinated individuals. A false-negative rate parallel to the estimated background prevalence in Aissa and colleagues' study is reassuring. The model predictions were also consistent when used in another contact group. However, such information cannot provide independent validation of the assumptions on which the model was built. Final proof of the model must therefore await longitudinal data on disease risk.

The risk of developing active TB is known to be much higher in the initial 2 years after infection (4, 12). This may be readily understandable if we assume there is biological variation in host vulnerability. More susceptible individuals are likely to be selected out, leaving the less vulnerable ones behind. Unfortunately, none of the currently available diagnostic tests are able to differentiate adequately between recent and remote infections (3, 4). The predictive model by Aissa and colleagues does not seem to help in this regard. Among the eight independent risk factors, the highest adjusted odds ratios were observed for age and birth in higher incidence countries, likely reflecting their effect on background prevalence of LTBI. A recent survey in the United States (1999–2000) showed the background rate of TB infection to vary from 1.8% in those born in the United States to 18.7% in foreign-born individuals (13). Therefore, the 8% of contacts with false-negative results in the model may not represent those 8% of individuals estimated to have remote infections. If increased age and birth in a higher incidence country were eliminated as predictive variables, the false-negative rate would increase and be above the estimate of the background rate of France. Nevertheless, it seems quite reasonable for the background rate of contacts to be higher than the population average, because the contacts tend to share the same environment, and presumably exposure risk, as their index cases. Again, longitudinal data on disease risk will be necessary to verify the various probability levels chosen for model calibration.

Smoking has been associated with both TB infection and disease (1, 14). For the relationship between smoking and TB infection, most evidence is based on TST, but suggestive association was observed in a recent study using an IGRA (15). Smoking is often assumed to be associated with multiple behavioral and social factors that might predispose to TB infection. However, the excess risk of infection was seen predominantly among current smokers, with ex-smokers being much less affected (1, 14, 15). The total number of cigarette pack-years did not, by itself, increase the odds of a positive test response (14, 15). Thus, increased exposure alone may not be sufficient to account for these observations.

We believe that, even though much is yet to be learned, in places where resources are limited and contact investigation is incomplete or not done using this model may be a reasonable approach. The model should help reduce costs and personnel burden, and should provide a pragmatic and effective form of contact investigation.

FOOTNOTES

Conflict of Interest Statement: None of the authors has a financial relationship with a commercial entity that has an interest in the subject of this manuscript.

REFERENCES

  1. Aissa K, Madhi F, Ronsin N, Delarocque F, Lecuyer A, Decludt B, Remus N, Abel L, Poirier C, Delacourt C; CG94 Study Group. Evaluation of a model for efficient screening of tuberculosis contact subjects. Am J Respir Crit Care Med 2008;177:1041–1047.[Abstract/Free Full Text]
  2. Bailey WC, Gerald LB, Kimerling ME, Redden D, Brook N, Bruce F, Tang S, Duncan S, Brooks CM, Dunlap NE. Predictive model to identify positive tuberculosis skin test results during contact investigations. JAMA 2002;287:996–1002.[Abstract/Free Full Text]
  3. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007;146:340–354.[Abstract/Free Full Text]
  4. American Thoracic Society; Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recommendations and Reports 2000;49:1–51.
  5. Leung CC, Tam CM, Chan SL, Chan-Yeung M, Chan CK, Chang KC. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong. Int J Tuberc Lung Dis 2001;5:717–723.[Medline]
  6. Chee CBE, Soh CH, Boudville LC, Chor SS, Wang YT. Interpretation of the tuberculin skin test in Mycobacterium bovis BCG-vaccinated Singaporean schoolchildren. Am J Respir Crit Care Med 2001;164:958–961.[Abstract/Free Full Text]
  7. Gerald LB, Tang S, Bruce F, Redden D, Kimerling ME, Brook N, Dunlap N, Bailey WC. A decision tree for tuberculosis contact investigation. Am J Respir Crit Care Med 2002;166:1122–1127.[Abstract/Free Full Text]
  8. Menzies R, Vissandjee B. Effect of bacille Calmette-Guerin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992;145:621–625.[Medline]
  9. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006;10:1192–1204.[Medline]
  10. Leung CC, Yew WW, Chang KC, Tam CM, Chan CK, Law WS, Wong MY, Lee SN, Leung M. Risk of active tuberculosis among schoolchildren in Hong Kong. Arch Pediatr Adolesc Med 2006;160:247–251.[Abstract/Free Full Text]
  11. Conseil Supérieur d'Hygiène Publique de France. TB case investigation: practice recommendations, 2006 [Internet] [accessed 2008 Jan 3]. Available from: http://www.sante.gouv.fr/htm/dossiers/tuberculose/reco_cshpf.pdf
  12. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis: a general review. Adv Tuberc Res 1970;17:28–106.
  13. Bennett DE, Courval JM, Onorato I, Agerton T, Gibson JD, Lambert L, McQuillan GM, Lewis B, Navin TR, Castro KG. Prevalence of tuberculosis infection in the United States population: the National Health and Nutrition Examination Survey, 1999–2000. Am J Respir Crit Care Med 2008;177:348–355.[Abstract/Free Full Text]
  14. Leung CC, Yew WW, Law WS, Tam CM, Leung M, Chung YW, Cheung KW, Chan KW, Fu F. Smoking and tuberculosis among silicotic patients. Eur Respir J 2007;29:745–750.[Abstract/Free Full Text]
  15. Leung CC, Yam WC, Yew WW, Ho PL, Tam CM, Law WS, Wong MY, Leung M, Tsui D. Comparison of T-Spot.TB and tuberculin skin test among silicotic patients. Eur Respir J 2008;31:266–272.[Abstract/Free Full Text]

Related articles in AJRCCM:

Evaluation of a Model for Efficient Screening of Tuberculosis Contact Subjects
Khaoula Aissa, Fouad Madhi, Nathalie Ronsin, France Delarocque, Aurélie Lecuyer, Bénédicte Decludt, Natacha Remus, Laurent Abel, Christine Poirier, Christophe Delacourt, and for the CG94 Study Group
AJRCCM 2008 177: 1041-1047. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
ChestHome page
R. Diel, R. Loddenkemper, K. Meywald-Walter, R. Gottschalk, and A. Nienhaus
Comparative Performance of Tuberculin Skin Test, QuantiFERON-TB-Gold In Tube Assay, and T-Spot.TB Test in Contact Investigations for Tuberculosis
Chest, April 1, 2009; 135(4): 1010 - 1018.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJRCCM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leung, C. C.
Right arrow Articles by Yew, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leung, C. C.
Right arrow Articles by Yew, W. W.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2008 American Thoracic Society